Rxivist logo

The Norepinephrine Metabolite DOPEGAL Confers Locus Coeruleus Tau Vulnerability and Propagation via Asparagine Endopeptidase

By Seong Su Kang, Xia Liu, Eun Hee Ahn, Jie Xiang, Fredric P Manfredsson, Xifei Yang, Hongbo R. Luo, L Cameron Liles, David Weinshenker, Keqiang Ye

Posted 02 Jul 2019
bioRxiv DOI: 10.1101/688200

Aberrant Tau inclusions in the locus coeruleus (LC) are the earliest detectable Alzheimer's disease (AD)-like neuropathology in the human brain; however, why LC neurons are selectively vulnerable to developing early Tau pathology and degenerating later in disease and whether the LC might seed the stereotypical spread of Tau pathology to the rest of the brain remain unclear. Here we show that 3,4-dihydroxyphenylglycolaldehyde (DOPEGAL), which is produced exclusively in noradrenergic neurons by monoamine oxidase A (MAO-A) metabolism of norepinephrine (NE), activates asparagine endopeptidase (AEP) that cleaves Tau at residue N368 into aggregation- and propagation-prone forms, thereby leading to LC degeneration and the spread of Tau pathology. DOPEGAL triggers AEP-cleaved Tau aggregation in vitro and in intact cells, resulting in LC neurotoxicity and propagation of pathology to the forebrain. Thus, our findings reveal a novel molecular mechanism underlying the selective vulnerability of LC neurons in AD.

Download data

  • Downloaded 423 times
  • Download rankings, all-time:
    • Site-wide: 79,263
    • In neuroscience: 11,717
  • Year to date:
    • Site-wide: 124,645
  • Since beginning of last month:
    • Site-wide: 140,017

Altmetric data

Downloads over time

Distribution of downloads per paper, site-wide